(+/-)-chloro-APB manufacturers
|
| | (+/-)-chloro-APB Basic information |
| Product Name: | (+/-)-chloro-APB | | Synonyms: | (+/-)-chloro-APB;1H-3-Benzazepine-7,8-diol,6-chloro-2,3,4,5-tetrahydro-1-phenyl-3-(2-propen-1-yl)-, hydrobromide (1:1);6-Chloro-2,3,4,5-tetrahydro-1-phenyl-3-(2-propen-1-yl)-1H-3-benzazepine-7,8-diol hydrobromide;(±)-SKF 82958 HYDROBROMIDE;CHLORO-APB HYDROBROMIDE;SKF 82958 hydrobromide,SKF82958 hydrobromide;(+/-)-6-Chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine HBr;SKF-82958 hydrobromide ((±)-SKF 82958 hydrobromide | | CAS: | 74115-01-8 | | MF: | C19H21BrClNO2 | | MW: | 410.74 | | EINECS: | | | Product Categories: | | | Mol File: | 74115-01-8.mol |  |
| | (+/-)-chloro-APB Chemical Properties |
| Melting point | 203-204 °C(Solv: isopropanol (67-63-0); ethyl ether (60-29-7)) | | storage temp. | Store at -20°C | | solubility | DMSO: 100 mM; Water: 5 mM, with warming | | form | A solid | | color | White to off-white |
| | (+/-)-chloro-APB Usage And Synthesis |
| Uses | SKF 82958 Hydrobromide is a dopamine (D1) agonist. Also, it augments GABAB inhibitory post-synaptic potentials (ipsp) in ventral tegmental area in brain slices. | | Hazard | A poison. | | in vivo | SKF-82958 ((±)-SKF 82958) hydrobromide (0.003-0.1 mg/kg; i.p.) results in dose-dependent increases in responding on the SKF-82958 appropriate lever, with full substitution following administration of the SKF-82958 hydrobromide training dose 0.03 mg/kg. Increasing the dose of SKF-82958 hydrobromide also results in a significant reduction in response rate[2].
SKF-82958 hydrobromide (0.5-2.0 mg/kg; i.p) significantly suppresses pilocarpine-induced jaw movements[3].
| Animal Model: | Male Sprague-Dawley rats[3] | | Dosage: | 0.5-2.0 mg/kg | | Administration: | I.p | | Result: | Significantly reduced the number of tremulous jaw movements induced by 4.0 mg/kg pilocarpine.
|
| | IC 50 | D1 Receptor |
| | (+/-)-chloro-APB Preparation Products And Raw materials |
|